Position in AMGN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$2,610,160
-$90,640 QoQ
Shares Held
7,208
-6.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#1,131
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LVW Advisors, LLC holds $27,389,756 across 12 Drug Manufacturers - General names. AMGN ranks #6 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,697 | $6,272,297 | |
| 2 | ABBV |
AbbVie Inc.
|
19,932 | $5,015,688 | |
| 3 | LLY |
ELI LILLY & Co
|
3,596 | $4,313,150 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
23,396 | $2,955,850 | |
| 5 | MRK |
Merck & Co., Inc.
|
22,654 | $2,911,039 | |
| 6 | AMGN |
Amgen Inc
This page
|
7,208 | $2,610,160 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,426 | $1,004,086 | |
| 8 | AZN |
Astrazeneca PLC
|
5,241 | $993,798 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,610,160 | 7,208 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $2,700,800 | 7,676 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $2,986,376 | 9,124 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,785,197 | 6,326 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,702,622 | 6,098 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,733,775 | 5,565 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,617,531 | 6,206 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $2,273,513 | 7,056 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $2,296,819 | 7,351 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $2,130,125 | 7,492 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $2,851,398 | 9,900 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $3,393,901 | 12,628 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $3,788,993 | 17,066 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $4,466,089 | 18,474 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $4,714,388 | 17,950 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $4,063,285 | 18,027 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $4,298,137 | 17,666 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $4,371,138 | 18,076 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $3,791,644 | 16,854 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $2,873,752 | 13,514 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $3,061,256 | 12,559 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $3,118,086 | 12,532 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $2,887,335 | 12,558 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $3,167,087 | 12,461 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $3,075,850 | 13,041 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $2,565,548 | 12,655 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||